Matthew Germinaro Selected Research

Matthew Germinaro Research Topics

4	Asthma (Bronchial Asthma) 01/2019 - 10/2016
2	Ulcerative Colitis 12/2023 - 01/2023
1	Hemorrhage 12/2023
1	Poisoning 01/2023
1	Colonic Neoplasms (Colon Cancer) 01/2023
1	COVID-19 01/2023
1	Tuberculosis (Tuberculoses) 01/2023
1	Crohn Disease (Crohn's Disease) 01/2022
1	Psoriasis (Pustulosis Palmaris et Plantaris) 01/2022
1	Psoriatic Arthritis 01/2022
1	Peanut Hypersensitivity (Peanut Allergy) 12/2019
1	Nasal Polyps (Nasal Polyp) 01/2019
1	Rhinosinusitis 01/2019
1	Common Variable Immunodeficiency 07/2015

4	Monoclonal AntibodiesIBA 01/2023 - 10/2016
4	reslizumabIBA 01/2019 - 10/2016
3	guselkumabIBA 12/2023 - 01/2022
2	Adrenal Cortex Hormones (Corticosteroids)IBA 12/2023 - 10/2016
1	Immunosuppressive Agents (Immunosuppressants)IBA 12/2023
1	golimumab FDA Link 01/2023
1	Interleukin-23 (Interleukin 23)IBA 01/2022
1	Biomarkers (Surrogate Marker)IBA 01/2022
1	Immunoglobulin E (IgE)IBA 12/2019
1	hypoxanthine arabinoside (ara-H)IBA 12/2019
1	EpitopesIBA 12/2019
1	Aspirin (Acetylsalicylic Acid)FDA LinkGeneric 01/2019
1	3- (2- (4- azidobenzamidino)ethyl)- 5- hydroxyindole (SABA)IBA 10/2016
1	B-Cell Activation Factor ReceptorIBA 07/2015